Martha Goldberg Aronson - 09 Aug 2021 Form 4 Insider Report for Cardiovascular Systems Inc

Role: Director
Signature: /s/ Andrew Nick as Attorney-in-Fact for Martha Goldberg Aronson pursuant to Power of Attorney filed herewith.
Issuer symbol: N/A
Transactions as of: 09 Aug 2021
Net transactions value: $0
Form type: 4
Filing time: 11 Aug 2021, 19:20:21 UTC
Previous filing: 03 Jun 2021
Next filing: 09 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	CSII	Common Stock						7,500	09 Aug 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CSII	Restricted Stock Units	Award	$0	+3,814		$0.000000	3,814	09 Aug 2021	Common Stock	3,814		Direct	F3
holding	CSII	Restricted Stock Units						16,938	09 Aug 2021	Common Stock	16,938		Direct	F1
holding	CSII	Restricted Stock Units						2,411	09 Aug 2021	Common Stock	2,411		Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents the right to receive a payment from the Company equal in value to the market price per share of Company common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning six months following the termination of the reporting person's board membership.
F2	Each restricted stock unit represents the right to receive a payment from the Company equal in value to the market price per share of Company common stock on the date of payment, and shall be payable in cash or shares of Company common stock on the payment date.
F3	Each restricted stock unit represents the right to receive a payment from the Company equal in value to the market price per share of Company common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning six months following the termination of the reporting person's board membership; provided, however, that the restricted stock units vest in quarterly amounts of 954 shares on each of September 30, 2021 and December 31, 2021 and as to 953 shares on each of March 31, 2022 and June 30, 2022.